What are the classifications of atrial fibrillation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 1, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Classification of Atrial Fibrillation

Atrial fibrillation is classified based on temporal patterns into five categories: first-diagnosed/newly detected AF, paroxysmal AF (self-terminating within ≤7 days), persistent AF (continuous >7 days requiring intervention), long-standing persistent AF (continuous ≥1 year with rhythm control still pursued), and permanent AF (continuous AF where restoration of sinus rhythm is no longer pursued). 1, 2, 3

Temporal Classification System

The current classification framework, harmonized across major international guidelines (ESC, AHA/ACC/HRS, CCS/CHRS), uses duration and persistence as the primary organizing principles:

First-Diagnosed/Newly Detected AF

  • The initial documentation of AF regardless of symptom status, duration, or previous undetected episodes 1, 4, 2
  • This category acknowledges uncertainty about actual arrhythmia onset
  • May represent either paroxysmal or persistent patterns at presentation

Paroxysmal AF

  • Episodes that self-terminate within 7 days (most within 48 hours) 1, 2, 3
  • Spontaneous termination is the defining feature
  • Mode of termination (spontaneous vs. cardioversion) does NOT change classification—if cardioversion is performed before 7 days, it remains paroxysmal 5

Persistent AF

  • Continuous AF episodes lasting >7 days 1, 2, 3
  • Requires intervention (pharmacological or electrical cardioversion) for termination
  • The 7-day cutoff is consistently applied across all major guidelines 4
  • Critical point: Once a patient has persistent AF, they remain classified as persistent even if they later become paroxysmal with therapy 2

Long-Standing Persistent AF

  • Continuous AF ≥1 year in duration 1, 2
  • Rhythm control strategy is still being pursued (distinguishes from permanent AF)
  • This category was introduced in 2010 ESC guidelines and subsequently adopted by AHA/ACC/HRS (2014) and CCS (2014) 4

Permanent AF

  • Continuous AF where patient and physician have jointly decided NOT to pursue sinus rhythm restoration 1, 5, 2, 3
  • This is a therapeutic decision, not a pathophysiological characteristic
  • The designation can be reversed if rhythm control is later reconsidered

Important Nuances and Caveats

Categories are not mutually exclusive: A patient may experience both paroxysmal and persistent episodes over time. Classify by the most frequent presentation pattern 5.

The term "chronic AF" is obsolete and should not be used 4.

Duration has dual meaning: It refers both to individual episode length and the total time a patient has been affected by AF 5.

Additional Classification Concepts

Primary vs. Secondary AF

The 2020 CCS/CHRS guidelines introduced this distinction 1:

  • Primary AF: Occurs in the context of an established pathophysiological process
  • Secondary AF: Occurs with a self-limited precipitant (e.g., post-cardiac surgery, acute illness, hyperthyroidism)
  • Note: The term "lone AF" (young patients without structural heart disease) is no longer recommended 1

Valvular vs. Nonvalvular AF

Current consensus across 2019-2020 guidelines 1:

  • Valvular AF: AF with mechanical heart valve OR moderate-to-severe mitral stenosis
  • Nonvalvular AF: All other AF cases
  • The ESC recommends abandoning the term "valvular AF" entirely, preferring precise terminology 1

Clinical vs. Subclinical AF

The 2024 guidelines distinguish 2, 3:

  • Clinical AF: Symptomatic or asymptomatic AF clearly documented by ECG (12-lead or other devices)
  • Subclinical AF: Arrhythmia identified in asymptomatic individuals without prior AF documentation, often detected by implanted devices or wearables
  • Atrial high-rate episodes (AHREs): Device-detected atrial events requiring visual confirmation to exclude artifact

AF Burden

Increasingly recognized as clinically relevant 2, 6:

  • Defined as the duration of AF episodes or percentage of time in AF during monitoring
  • No standardized definition exists across studies
  • May influence anticoagulation decisions in subclinical AF

Practical Application

When classifying a patient:

  1. First encounter: Label as "first-diagnosed" or "newly detected"
  2. Subsequent episodes: Determine if self-terminating (<7 days = paroxysmal) or requiring intervention (>7 days = persistent)
  3. Long-term pattern: If persistent AF continues ≥1 year with ongoing rhythm control attempts = long-standing persistent
  4. Therapeutic decision: If rhythm control abandoned = permanent (reversible designation)
  5. Context matters: Identify if secondary to reversible precipitant (post-operative, acute illness)

The classification directly impacts management decisions: Paroxysmal AF may be more amenable to catheter ablation, while permanent AF focuses on rate control and anticoagulation without rhythm control strategies 2, 3.

References

Research

Clinical classification and the subclinical atrial fibrillation challenge: a position paper of the European Cardiac Arrhythmia Society.

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.